$31.00
0.99 (+3.30%)
Medivation, Inc. (MDVN)
CAPS Rating:
A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies.
A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies.